Literature DB >> 27865287

Surgical Management of Pancreatic Neuroendocrine Tumors.

Jason B Liu1, Marshall S Baker2.   

Abstract

Pancreatic neuroendocrine tumors (PNETs) are a rare, heterogeneous group of neoplasms infamous for their endocrinopathies. Up to 90% of PNETs, however, are nonfunctional and are frequently detected incidentally on axial imaging during the evaluation of vague abdominal symptoms. Surgery remains the mainstay of therapy for patients diagnosed with both functional and nonfunctional PNETs. However, the multifaceted nature of PNETs challenges treatment decision making. In general, resection is recommended for patients with acceptable perioperative risk and amenable lesions.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Management; PNET; Pancreatic neuroendocrine tumor; Review; Surgery

Mesh:

Year:  2016        PMID: 27865287     DOI: 10.1016/j.suc.2016.07.002

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  7 in total

Review 1.  Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management.

Authors:  Zu-Yi Ma; Yuan-Feng Gong; Hong-Kai Zhuang; Zi-Xuan Zhou; Shan-Zhou Huang; Yi-Ping Zou; Bo-Wen Huang; Zhong-Hai Sun; Chuan-Zhao Zhang; Yun-Qiang Tang; Bao-Hua Hou
Journal:  World J Gastroenterol       Date:  2020-05-21       Impact factor: 5.742

Review 2.  Surgical resection of pancreatic neuroendocrine neoplasm by minimally invasive surgery-the robotic approach?

Authors:  Roxanne Y A Teo; Brian K P Goh
Journal:  Gland Surg       Date:  2018-02

3.  Role of Tumor-Associated Macrophages in the Clinical Course of Pancreatic Neuroendocrine Tumors (PanNETs).

Authors:  Lei Cai; Theodoros Michelakos; Vikram Deshpande; Kshitij S Arora; Teppei Yamada; David T Ting; Marty S Taylor; Carlos Fernandez-Del Castillo; Andrew L Warshaw; Keith D Lillemoe; Soldano Ferrone; Cristina R Ferrone
Journal:  Clin Cancer Res       Date:  2019-01-22       Impact factor: 12.531

4.  Robotic enucleations of pancreatic benign or low-grade malignant tumors: preliminary results and comparison with robotic demolitive resections.

Authors:  Ilenia Bartolini; Lapo Bencini; Marco Bernini; Marco Farsi; Massimo Calistri; Mario Annecchiarico; Luca Moraldi; Andrea Coratti
Journal:  Surg Endosc       Date:  2018-11-12       Impact factor: 4.584

Review 5.  Systematic Review and Metaanalysis of Lymph Node Metastases of Resected Pancreatic Neuroendocrine Tumors.

Authors:  Masayuki Tanaka; Max Heckler; André L Mihaljevic; Pascal Probst; Ulla Klaiber; Ulrike Heger; Simon Schimmack; Markus W Büchler; Thilo Hackert
Journal:  Ann Surg Oncol       Date:  2020-07-27       Impact factor: 5.344

6.  Impact of Surgery on Non-Functional Pancreatic Neuroendocrine Tumors ≤2 cm: Analyses With Propensity Score-Based Inverse Probability of Treatment Weighting.

Authors:  Jingyuan Ye; Hongyu Wu; Jinzheng Li; Changan Liu
Journal:  Front Surg       Date:  2022-07-08

Review 7.  Current Management of Pancreatic Neuroendocrine Tumors: From Demolitive Surgery to Observation.

Authors:  Ilenia Bartolini; Lapo Bencini; Matteo Risaliti; Maria Novella Ringressi; Luca Moraldi; Antonio Taddei
Journal:  Gastroenterol Res Pract       Date:  2018-07-22       Impact factor: 2.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.